Scienture
Scienture: Advancing novel drug research and development to address unmet medical needs.
Founded
2019Scienture: Advancing novel drug research and development to address unmet medical needs.
Scienture differentiates itself through ready-to-use and high-dose formulations of well-established medicines, positioning its products as alternatives to compounding or lower-dose options. Arbli is described as the first FDA-approved ready-to-use oral liquid losartan potassium, and REZENOPY as the highest-dose FDA-approved naloxone nasal spray in the United States.
The company pairs product differentiation with commercial capabilities spanning manufacturing, sales, marketing, and market access, and has secured formulary coverage and wholesale distribution for its launched products. Patent protection extending through 2041 supports the long-term exclusivity of both commercial products.
Source: scienture.com
Scienture operates in the U.S. specialty pharmaceutical market, where demand for patient-friendly formulations and accessible emergency treatments continues to shape product adoption. Its commercial strategy focuses on payer coverage, wholesale distribution, and partnerships that broaden patient access to its launched products.
The company's stated objective is to expand its portfolio and shareholder value while pursuing additional clinical solutions, supported by financing and the continuing commercialization of Arbli and REZENOPY. Continued growth depends on market-access expansion, pipeline advancement, and sustained commercial execution.
Source: scienture.com
Scienture commercializes specialty pharmaceutical products designed to address adherence, formulation, and access gaps for patients and healthcare systems. Its portfolio centers on differentiated formulations of established medicines, developed and brought to market through a U.S.-focused commercial organization.
The company's commercial products are Arbli (losartan potassium) oral suspension 10 mg/mL for cardiovascular use and REZENOPY (naloxone HCl) nasal spray 10 mg for emergency treatment of opioid overdose. Scienture also maintains an early-stage pipeline spanning central nervous system, pain, and cardiovascular indications.
Source: scienture.com